RFPL4B
Ret finger protein-like 4B
Also known as: RFPLB_HUMAN, RNF211
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZWI9
- Gene
- RFPL4B
- Ensembl
- ENSG00000251258
- Chromosome
- 6
- Canonical length
- 263 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
263 residues, UniProt reviewed canonical sequence.
>Q6ZWI9|RFPL4B
1 MAKRLQAELS CPVCLDFFSC SISLSCTHVF CFDCIQRYIL ENHDFRAMCP LCRDVVKVPA
61 LEEWQVSVLT LMTKQHNSRL EQSLHVREEL RHFREDVTLD AATASSLLVF SNDLRSAQCK
121 KIHHDLTKDP RLACVLGTPC FSSGQHYWEV EVGEVKSWSL GVCKEPADRK SNDLFPEHGF
181 WISMKAGAIH ANTHLERIPA SPRLRRVGIF LDADLEEIQF FDVDNNVLIY THDGFFSLEL
241 LCPFFCLELL GEGESGNVLT ICPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFPL4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 1.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 1.5 nTPM
- kidney: 0.3 nTPM
- placenta: 0.3 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- extravillous trophoblasts: 23 nCPM
- undifferentiated spermatogonia: 4.6 nCPM
- late primary spermatocytes: 3.3 nCPM
- differentiating spermatogonia: 1.8 nCPM
- migrating cytotrophoblasts: 1.6 nCPM
- early primary spermatocytes: 1.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- B30.2/SPRY domain
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- Zinc finger, RING-type, conserved site
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- SPRY-associated domain
- zinc finger of C3HC4-type, RING
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFPL4B as an antibody target. Whether an autoantibody or antibody against RFPL4B could matter depends on whether native RFPL4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFPL4B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFPL4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...